Akero Therapeutics (AKRO) reported 96-week data in its trial of advanced MASH patients, and there seem really significant ...

The results of a phase 2b ENLIVEN trial of FGF21 analogue pegozafermin showed it was able to reduce scarring (fibrosis) in the liver of NASH patients at more than three times the rate of a placebo ...

Sino Biological provides recombinant NASH-related drug targets to ... injected hyperglycemic mice with human recombinant FGF21 from Sino Biological to study the synergistic effect of FOXO1 ...

The team behind the work, led by UT Southwestern Medical Center researchers David Mangelsdorf and Steven Kliewer, exposed control and mice engineered to lack FGF21 to a single dose of ethanol—an ...

FGF21 knockout mice (FGF21 KO) show inhibition of remyelination and functional recovery after demyelination. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases ...

The study indicated that increasing the population of Bacteroides vulgatus in diabetic mice contributed to the ... leading to decreased release of the hormone FGF21, which is associated with ...